PGR
63
3
SIG
49
6
CTSH
54
-2
DE
56
10
EQIX
62
2
AXP
69
3
ABBV
39
8
MAS
56
5
CVX
44
-2
AIV
70
2
DLTR
38
4
FRT
45
6
BK
72
4
CTAS
59
4
ILMN
37
5
WU
30
6
BMY
58
5
FTI
76
3
BIIB
28
2
JPM
67
4
PGR
63
3
SIG
49
6
CTSH
54
-2
DE
56
10
EQIX
62
2
AXP
69
3
ABBV
39
8
MAS
56
5
CVX
44
-2
AIV
70
2
DLTR
38
4
FRT
45
6
BK
72
4
CTAS
59
4
ILMN
37
5
WU
30
6
BMY
58
5
FTI
76
3
BIIB
28
2
JPM
67
4
Financhill
Back

Beam Therapeutics Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52

BEAM
Beam Therapeutics

Last Price:
24.61
Seasonality Move:
42.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...

Beam Therapeutics Stock Forecast

  • Over the next 52 weeks, Beam Therapeutics has on average historically risen by 8.9% based on the past 4 years of stock performance.
  • Beam Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is Beam Therapeutics Stock Undervalued?
    The current Beam Therapeutics [BEAM] share price is $23.58. The Score for BEAM is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • BEAM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Beam Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Beam Therapeutics has on average historically risen by 8.9% based on the past 4 years of stock performance.

Beam Therapeutics Stock Rating

Buy
52
Beam Therapeutics (BEAM) is a Buy

Is Beam Therapeutics overpriced?

  • Beam Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Beam Therapeutics Stock Price History

Is BEAM stock going to rise?

  • The current trend is relatively stagnant and BEAM is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
beamtx.com

52-Week Data

52-Week High:
49.50
52-Week Low:
20.84

Prediction Charts

Market Cap:
1.95B
Price in USD:
23.58
Volume:
1.01M
Beta:
1.79

Technical Analysis

SMA50:
24.54
SMA100:
25.30
SMA200:
26.78
52-Wk Change:
-15.64%

Stock Predictions

  • Is Beam Therapeutics stock public?
    Yes, Beam Therapeutics is a publicly traded company.
  • What is the Beam Therapeutics stock quote today?
    The Beam Therapeutics stock price is 23.58 USD today.
  • How to buy Beam Therapeutics stock online?
    You can buy Beam Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-4 22.75 24.36 24.95 22.52
Nov-5 21.62 23.93 24.79 21.46
Nov-6 26.00 26.62 27.30 25.24
Nov-7 26.56 26.09 27.17 25.60
Nov-8 25.88 27.06 27.38 25.68
Nov-11 27.58 30.38 32.29 27.50
Nov-12 29.69 27.94 30.66 27.38
Nov-13 28.22 27.50 28.91 27.15
Nov-14 27.55 26.31 27.82 26.20
Nov-15 26.44 24.05 26.44 23.62
Nov-18 24.80 24.12 25.05 23.72
Nov-19 23.75 25.29 25.39 23.67
Nov-20 25.25 24.49 25.87 24.39
Nov-21 24.53 23.58 24.71 23.33

Beam Therapeutics Earnings

Beam Therapeutics Earnings Report: Per Share Beam Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Beam Therapeutics Forecast Revenue Growth

Beam Therapeutics Stock Analysis: Historical quarterly revenues per share for Beam Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.58 per share, and a decrease next year of $0.04 per share.

* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.